Sudden cardiac death in young athletes: Literature review of molecular basis

  • Cristina Mazzaccara Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II; CEINGE Advanced Biotechnologies, Naples, Italy.
  • Bruno Mirra Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II; CEINGE Advanced Biotechnologies, Naples, Italy.
  • Ferdinando Barretta Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II; CEINGE Advanced Biotechnologies, Naples, Italy.
  • Barbara Lombardo Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II; CEINGE Advanced Biotechnologies, Naples, Italy.
  • Olga Scudiero Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II; CEINGE Advanced Biotechnologies, Naples, Italy.
  • Giulia Frisso | gfrisso@unina.it Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II; CEINGE Advanced Biotechnologies, Naples, Italy.

Abstract

Intense athletic training and competition can rarely result in sudden cardiac death (SCD). Despite the introduction of pre-participation cardiovascular screening, especially among young competitive athletes, sport-related SCD remains a debated issue among medical personnel, sports communities and laypersons alike, and generates significant media attention. The most frequent cause of SCD is a hidden inherited cardiomyopathy, the athletes may not even be aware of. Predictive medicine, by searching the presence of pathogenic alterations in cardiac genes, may be an integrative tool, besides the conventional ones used in cardiology (mainly electro and echocardiogram), to reach a definitive diagnosis in athletes showing signs/symptoms, even borderline, of inherited cardiomyopathy/ channelopathy, and in athletes presenting family history of SCD and/or of hereditary cardiac disease. In this review, we revised the molecular basis of the major cardiac diseases associated to sudden cardiac death and the clinical molecular biology approach that can be used to perform risk assessment at DNA level of sudden cardiac death, contributing to the early implementation of adequate therapy. Alterations can occur in ion channel genes, in genes encoding desmosomal and junctional proteins, sarcomeric and Z-disc proteins, proteins for the cytoskeleton and the nuclear envelope. The advent of next generation sequencing (NGS) technology has provided the means to search for mutations in all these genes, at the same time. Therefore, this molecular approach should be the preferred methodology for the aforementioned purpose.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.
Published
2020-04-07
Info
Issue
Section
Review Articles
Keywords:
Sudden cardiac death, cardiomyopathy, genetic testing, athletes.
Statistics
  • Abstract views: 275

  • PDF: 118
  • Appendix Table 1: 91
How to Cite
Mazzaccara, C., Mirra, B., Barretta, F., Lombardo, B., Scudiero, O., & Frisso, G. (2020). Sudden cardiac death in young athletes: Literature review of molecular basis. Cardiogenetics, 10(1). https://doi.org/10.4081/cardiogenetics.2020.8860